by Office for Official Publications of the European Communities in Luxembourg .
Written in English
|Statement||Geertrui Van Overwalle|
|Contributions||European Group on Ethics in Science and new Technologies to the European Commission|
|The Physical Object|
|Pagination||218 p. :|
|Number of Pages||218|
The Last Taboo: Patenting Human Beings of Inventions Related to Human Stem Cell Research policy and patent legislation on human stem cell research was gathered in order to enable the EGE Author: Matthew Rimmer. People question both the legitimacy of human embryonic stem cell research and the state granted monopoly on related research findings. In addition, it is questionable whether patent law, in its current form, can keep the perfect balance between stimulating hESC innovation in industry and ensuring that patients can benefit from inventions. [Show full abstract] opinion to be issued would deal with the use of human stem cells and the patentability of the inventions deriving from such report was developed in response to. Three human embryonic stem cell patents are held by the Wisconsin Alumni Research Foundation (WARF) in the United States. These are based .
A Study on the Patentability of Inventions related to Human Embryonic Stem Cells in Korea with that of the world’s leading countries and also accelerating the technological transfer of biotechnology research to commercial applications. Ahn MC. () A Study on the Patentability of Inventions related to Human Embryonic Stem Cells in Author: Mi-Chung Ahn. Introduction. As predicted in this journal in , the policy battles concerning human embryonic stem cells have shifted from controversies concerning research on human embryos to skirmishes related to intellectual property rights .In the United States (US), the Wisconsin Alumni Research Foundation (WARF) owns three patents on human embryonic stem cells based on University of Wisconsin Cited by: The book finally proposed an approach for china to regulating human embryonic stem cell research-regulating research itself at the reconciled international regime. The potential reader includes academics and practitioners dealing with intellectual property, patent law and stem cell inventions. With its broad research in the fields of patent law, ethics and philosophy, the book analyzes a wide range of issues in a way no other book has previously done and suggests solutions to unblock the current stalemate surrounding the patentability of human embryonic stem cell related inventions. The book will be welcomed by a broad readership Cited by: 4.
Human Stem Cell Research and Regenerative Medicine Stem cell research is a field that has generated much 3 activity in laboratories, media offices and higher courts. Parallel to the potential new treatments for incurable diseases and opportunities for bioen-trepreneurs, heated ethical and legal debates have arisen around the Size: 2MB. The ban on patenting embryonic stem cells in the EU is currently being challenged by groups in Britain who have been joined by a high court judge who has asked the CJEU to clarify its decision to prevent the patenting of stem cell research involving the Cited by: 4. THE OWNERSHIP AND PATENTING OF INVENTIONS RESULTING FROM STEM CELL RESEARCH John A. Lee* I. INTRODUCTION On August 9, , President George W. Bush announced the administration's stem cell research policy-the National Insti-tutes of Health (NIH) would only grant funds to research pro-jects using pre-existing stem cell lines.'Cited by: 1. the patenting of isolated stem cell lines. The authors argue that because the isolation of stem cells implies modification, product patents should apply where the results are novel due to the fact that they believe that an isolated embryonic stem cell represents a culture artefact and .